Continue to content

BHS webinar supported by Pfizer: Insights into the Latest and Future Treatment Approaches for Relapsed/Refractory Multiple Myeloma

20 June 2024

Online 

Organised by
BHS
In collaboration with
Pfizer

Thursday 21 March 2024, 19:00 - 20:00

PROGRAMME

Chair & moderation : Prof. Michel Delforge (UZ Leuven)

  • 19:00 Welcome & Introduction
  • 19:05 How to navigate through the evolving landscape of immunotherapy for relapsed refractory multiple myeloma (Dr. Marie Vercruysse - HUB)
  • 19:25 How I treat relapsed refractory multiple myeloma patients with BsAbs (Dr. Ann Van De Velde - UZA)
  • 19:45 Discussion and Q&A
  • 40th General Annual Meeting of the Belgian Hematology Society 2025

    7/02/2025 - 8/02/2025
    Dolce La Hulpe Brussels
  • POST-ASH 2025

    17/01/2025 - 17/01/2025
    Sheraton Brussels Airport HotelJoin us at the next edition of the POST-ASH to be held on Friday, 17 January at the Sheraton Brussels…
  • BHS Webinar supported by Lilly

    19/12/2024 - 19/12/2024
    How to improve care of MCL patients in the future: The big debate – Pros & Cons